Endo Usa Inc., A Keenova Therapeutics Company
Clinical trials sponsored by Endo Usa Inc., A Keenova Therapeutics Company, explained in plain language.
Pharmaceutical company focused on branded and generic pain management and urology products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New shot could ease pain of rare foot condition
Symptom relief CompletedThis phase 3 study tests an injection called EN3835 against a placebo for people with Ledderhose disease, which causes painful lumps on the soles of the feet. About 418 adults with foot pain from this condition will receive either the drug or a placebo. The main goal is to see if…
Phase: PHASE3 • Sponsor: Endo USA Inc., a Keenova Therapeutics Company • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New shot could ease pain of plantar fibromatosis
Symptom relief CompletedThis study tested an injection called EN3835 against a placebo in 176 people with plantar fibromatosis, a condition causing painful lumps on the soles of the feet. The goal was to see if EN3835 reduces foot pain and improves daily function over 57 days. Participants received up t…
Phase: PHASE2 • Sponsor: Endo USA Inc., a Keenova Therapeutics Company • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New shot could ease chronic heel pain
Symptom relief CompletedThis study tested two doses of an injected biologic called EN3835 (collagenase) against a placebo in 231 adults with plantar fasciitis lasting at least 6 months. The goal was to see if it reduces daily heel pain and improves foot function over 12 weeks. Results are complete and w…
Phase: PHASE2 • Sponsor: Endo USA Inc., a Keenova Therapeutics Company • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC